EPD Biotherapeutics is a startup co-founded by Choi Jae-hyun, who worked at Arvinas, the world's best technology company, in PROTAC (a structure that connects warhead that binds to target protein to E3 ligase with linker). Futureplay's first Bio-pharma portfolio was established to overcome the limitations of PROTAC based on low molecular compounds.